Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 05:39:25 GMT 2023
by
admin
on
Sat Dec 16 05:39:25 GMT 2023
|
| Protein Type | MONOCLONAL ANTIBODY |
| Protein Sub Type | IGG2A |
| Sequence Origin | HUMAN |
| Sequence Type | COMPLETE |
| Record UNII |
716FQ5REVO
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C20401
Created by
admin on Sat Dec 16 05:39:25 GMT 2023 , Edited by admin on Sat Dec 16 05:39:25 GMT 2023
|
||
|
NCI_THESAURUS |
C129822
Created by
admin on Sat Dec 16 05:39:25 GMT 2023 , Edited by admin on Sat Dec 16 05:39:25 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
716FQ5REVO
Created by
admin on Sat Dec 16 05:39:25 GMT 2023 , Edited by admin on Sat Dec 16 05:39:25 GMT 2023
|
PRIMARY | |||
|
DB12261
Created by
admin on Sat Dec 16 05:39:25 GMT 2023 , Edited by admin on Sat Dec 16 05:39:25 GMT 2023
|
PRIMARY | |||
|
BC-56
Created by
admin on Sat Dec 16 05:39:25 GMT 2023 , Edited by admin on Sat Dec 16 05:39:25 GMT 2023
|
PRIMARY | |||
|
C91073
Created by
admin on Sat Dec 16 05:39:25 GMT 2023 , Edited by admin on Sat Dec 16 05:39:25 GMT 2023
|
PRIMARY | |||
|
1463459-96-2
Created by
admin on Sat Dec 16 05:39:25 GMT 2023 , Edited by admin on Sat Dec 16 05:39:25 GMT 2023
|
PRIMARY | |||
|
10106
Created by
admin on Sat Dec 16 05:39:25 GMT 2023 , Edited by admin on Sat Dec 16 05:39:25 GMT 2023
|
PRIMARY | |||
|
CHEMBL2109295
Created by
admin on Sat Dec 16 05:39:25 GMT 2023 , Edited by admin on Sat Dec 16 05:39:25 GMT 2023
|
PRIMARY | |||
|
SUB181657
Created by
admin on Sat Dec 16 05:39:25 GMT 2023 , Edited by admin on Sat Dec 16 05:39:25 GMT 2023
|
PRIMARY | |||
|
Ascrinvacumab
Created by
admin on Sat Dec 16 05:39:25 GMT 2023 , Edited by admin on Sat Dec 16 05:39:25 GMT 2023
|
PRIMARY |
| From | To |
|---|---|
| 1_22 | 1_97 |
| 2_22 | 2_97 |
| 3_23 | 3_89 |
| 4_23 | 4_89 |
| 1_132 | 3_215 |
| 2_132 | 4_215 |
| 3_135 | 3_195 |
| 4_135 | 4_195 |
| 1_145 | 1_201 |
| 2_145 | 2_201 |
| 1_220 | 2_220 |
| 1_221 | 2_221 |
| 1_224 | 2_224 |
| 1_227 | 2_227 |
| 1_258 | 1_318 |
| 2_258 | 2_318 |
| 1_364 | 1_422 |
| 2_364 | 2_422 |
| Glycosylation Type | MAMMALIAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_294 |
| N | 2_294 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
||||
| Molecular Formula | CHEMICAL |
|